Related Experiment Videos
Structure and expression of human IFN-alpha genes.
Summary
Researchers cloned interferon-alpha (IFN-alpha) complementary DNA (cDNA) in E. coli, identifying multiple genes and their evolutionary divergence. They also engineered cells to produce functional IFN-alpha, advancing therapeutic potential.
Area of Science:
- Molecular Biology
- Immunology
- Genetics
Background:
- Interferons (IFNs) are crucial for antiviral responses.
- Understanding IFN-alpha gene structure and evolution is key to their therapeutic application.
Purpose of the Study:
- To clone and characterize human interferon-alpha (IFN-alpha) complementary DNA (cDNA).
- To investigate the human IFN-alpha gene family and its evolutionary history.
- To express functional IFN-alpha in bacterial and mammalian systems.
Main Methods:
- cDNA cloning from induced leucocyte poly(A) RNA in Escherichia coli.
- Translation hybridization assays for clone identification.
- Screening of a human chromosomal library with IFN cDNA.
- Gene sequencing and phylogenetic analysis.
- Expression of IFN-alpha genes in E. coli and mammalian cell lines.
Main Results:
- Isolation and identification of multiple IFN-alpha cDNA clones encoding mature polypeptides and signal sequences.
- Characterization of the human IFN-alpha gene family, including authentic genes, pseudogenes, and allelic variants.
- Classification of IFN-alpha genes into two subfamilies with ancient divergence.
- Successful expression of mature IFN-alpha in E. coli and functional IFN-alpha production in engineered hamster cells.
- Demonstration of hybrid IFN gene specificities and expression of human IFN-alpha in mouse cells.
Conclusions:
- The human genome contains a complex family of IFN-alpha genes with significant evolutionary history.
- Recombinant DNA technology allows for the high-yield production of functional IFN-alpha in prokaryotic and eukaryotic systems.
- Engineered mammalian cells can constitutively produce biologically active interferons, offering therapeutic potential.